Anavex

-$3.07 (-14.37%) Today
+$0.22 (+1.20%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Anavex and other ETFs, options, and stocks.

About AVXL

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome.

CEO
Christopher U. Missling
Employees
20
Headquarters
New York, New York
Founded
2004

AVXL Key Statistics

Market Cap
1.32B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.00M
High Today
$21.99
Low Today
$18.19
Open Price
$21.93
Volume
5.04M
52 Week High
$31.50
52 Week Low
$3.65

AVXL News

Yahoo FinanceJul 26

Anavex Life Sciences CEO discusses trials of new Parkinson's and dementia drugs

Yahoo Finance's Myles Udland talks with Anavex Life Sciences CEO Christopher Missling about the company's new Parkinson's disease drugs as well as its recent ca

AVXL Earnings

-$0.14
-$0.09
-$0.05
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Aug 12, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure